New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Two new studies show how bacteria could help tumors progress and resist treatment

Two new studies show how bacteria could help tumors progress and resist treatment

byFred Hutchinson Cancer Research CenterCredit: CC0 Public DomainTwo new studies from researchers at Fred Hutchinson Cancer Center in Seattle reveal how bacteria infiltrate tumors and could be h
Oncology December 28,2023
Two new studies show how bacteria could help tumors progress and resist treatment

Two new studies show how bacteria could help tumors progress and resist treatment

byFred Hutchinson Cancer Research CenterCredit: CC0 Public DomainTwo new studies from researchers at Fred Hutchinson Cancer Center in Seattle reveal how bacteria infiltrate tumors and could be h
Oncology December 28,2023
Two genomic studies could yield more effective, less toxic immunotherapies

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th
Oncology December 28,2023
Two genomic studies could yield more effective, less toxic immunotherapies

Two genomic studies could yield more effective, less toxic immunotherapies

by Institut CurieTE-Exon splicing junctions can help differentiate tumors from healthy tissue. Credit: Verge Scientific Communications / Antonela Merlotti / Marianne Burbage / Benjamin SadaccaMnemo Th
Oncology December 28,2023
New lease on life for two lung cancer patients after pioneering double-lung transplant

New lease on life for two lung cancer patients after pioneering double-lung transplant

by Cara MurezRetired nurse Tannaz Ameli was diagnosed with stage 4 lung cancer last winter. When chemotherapy failed, her doctors recommended hospice care.But Ameli, of Minneapolis, had other ideas. S
Oncology December 28,2023
New lease on life for two lung cancer patients after pioneering double-lung transplant

New lease on life for two lung cancer patients after pioneering double-lung transplant

by Cara MurezRetired nurse Tannaz Ameli was diagnosed with stage 4 lung cancer last winter. When chemotherapy failed, her doctors recommended hospice care.But Ameli, of Minneapolis, had other ideas. S
Oncology December 28,2023
Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy
Oncology December 28,2023
Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

Combination treatment shows promise in patients with chemotherapy-resistant urothelial cancer

byWolters Kluwer HealthGraphical abstract. Credit:Journal of Urology(2022). DOI: 10.1097/JU.0000000000002969A combination of two types of cancer-fighting treatments—the immunotherapy
Oncology December 28,2023
Drug combination shows potential in aggressive leukemia

Drug combination shows potential in aggressive leukemia

by Blake Belden,Virginia Commonwealth UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainAcute myeloid leukemia (AML) is an aggressive form of cancer that originates in
Oncology December 28,2023
Drug combination shows potential in aggressive leukemia

Drug combination shows potential in aggressive leukemia

by Blake Belden,Virginia Commonwealth UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainAcute myeloid leukemia (AML) is an aggressive form of cancer that originates in
Oncology December 28,2023
Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient
Oncology December 28,2023
Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient
Oncology December 28,2023
Exploiting the synergy of nutraceuticals for cancer prevention and treatment

Exploiting the synergy of nutraceuticals for cancer prevention and treatment

by Cactus CommunicationsResearchers from Tata Memorial Centre, India, demonstrate how a resveratrol-copper mix inactivates cell-free chromatic particles to ameliorate a host of pathologies, including
Oncology December 28,2023
Exploiting the synergy of nutraceuticals for cancer prevention and treatment

Exploiting the synergy of nutraceuticals for cancer prevention and treatment

by Cactus CommunicationsResearchers from Tata Memorial Centre, India, demonstrate how a resveratrol-copper mix inactivates cell-free chromatic particles to ameliorate a host of pathologies, including
Oncology December 28,2023
Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January
Oncology December 28,2023
Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

by Impact Journals LLCThe use of PDC*vac platform to develop NeoAg-based cancer vaccines. Credit: 2023 Hannani et al.A new research perspective was published inGenes & Canceron January
Oncology December 28,2023
New hope for kidney cancer treatment using existing drugs

New hope for kidney cancer treatment using existing drugs

byWellcome Trust Sanger InstituteCredit: Omer Bayraktar & Kenny RobertsThe most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat rena
Oncology December 28,2023
New hope for kidney cancer treatment using existing drugs

New hope for kidney cancer treatment using existing drugs

byWellcome Trust Sanger InstituteCredit: Omer Bayraktar & Kenny RobertsThe most comprehensive study of kidney cancer at single-cell level has discovered a potential drug target to treat rena
Oncology December 28,2023
Finding molecular secrets hidden in premature aging diseases and cancer using AI

Finding molecular secrets hidden in premature aging diseases and cancer using AI

byInsilico MedicineSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been examined in
Oncology December 28,2023
Finding molecular secrets hidden in premature aging diseases and cancer using AI

Finding molecular secrets hidden in premature aging diseases and cancer using AI

byInsilico MedicineSchematic representation of the PandaOmics application for a rapid biomarker discovery and target characterization in cancer. Gene expression signatures have been examined in
Oncology December 28,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com